Evaluation of LI-RADS 3 category by magnetic resonance in US-detected nodules ≤ 2 cm in cirrhotic patients
Sign Up to like & getrecommendations! Published in 2021 at "European Radiology"
DOI: 10.1007/s00330-020-07457-6
Abstract: Liver Imaging Reporting and Data System (LI-RADS) for hepatocellular carcinoma (HCC) diagnosis in high-risk patients is a dynamic system, which was lastly updated in 2018. We aimed to evaluate the accuracy for HCC diagnosis of… read more here.
Keywords: hcc diagnosis; cirrhotic patients; magnetic resonance; hcc ... See more keywords
Hepatocellular carcinoma development in diabetic patients: a nationwide survey in Japan
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Gastroenterology"
DOI: 10.1007/s00535-020-01754-z
Abstract: Although type 2 diabetes mellitus (T2DM) is a known risk factor for hepatocellular carcinoma (HCC) development, the annual incidence in diabetes patients is far below the threshold of efficient surveillance. This study aimed to elucidate… read more here.
Keywords: hepatocellular carcinoma; hcc; diabetic patients; hcc diagnosis ... See more keywords
Diagnostic implication of a circulating serum-based three-microRNA signature in hepatocellular carcinoma
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Genetics"
DOI: 10.3389/fgene.2022.929787
Abstract: Owing to the diagnostic dilemma, the prognosis of hepatocellular carcinoma (HCC) remains impoverished, contributing to the globally high mortality rate. Currently, HCC diagnosis depends on the combination of imaging modalities and the measurement of serum… read more here.
Keywords: hepatocellular carcinoma; hcc diagnosis; serum; hcc ... See more keywords